A handout by DRAP on its official website late Monday read that Sinopharm, one of the two vaccines approved by the authority, has been given emergency use authorization after evaluating its safety and quality.
The authority said the authorization will be reviewed every quarter keeping in view further data regarding safety, efficacy and quality.
A vaccine manufactured by British-Swedish pharmaceutical company AstraZeneca has also been given the authorization earlier, the handout said.
Chaudhry Fawad Hussain, the country’s minister for science and technology, told Xinhua earlier that the Sinopharm vaccine has been approved for procurement by a cabinet committee for its safety and affordability.
Short Link: https://wp.me/pcj2iU-3xG3
- Ghana denies Akufo-Addo’s alleged conviction against Nigeria
- Tragic death of Bello Africa’s best para-badminton player – Kwara gov.
- Presidency condemns smear campaign against Minister of Communication Pantami
- Ramadan: Governor Lalong and Onaiyekan call for peace and religious tolerance
- Zamfara’s killing of innocent people by bandits is unacceptable – Buhari
- FG reaffirms its commitment to finance the schools of the unit
- ACCI entrusts the private sector with piloting the agro-industrial zones
- COVID-19: 16.6 million African children miss doses of measles vaccine – WHO
- FG reiterates its commitment to the industrial property legislature